This week, Q-Med, the Swedish pharmceutical company that is the home to Restylane and Perlane, announced Restylane® Lidocaine and Restylane Perlane™ Lidocaine as the latest additions to their Restylane family of dermal fillers. These products have the familiar Restylane and Perlane hyaluronic gel fillers, together with a small amount (0.3 %) of lidocaine, a commonly used […]
Botox competitor “Reloxin” (sold in Europe as “Dysport”) received its FDA approval today. The FDA decided to approve both the cosmetic indications (for wrinkles) and the functional indications (cervical dystonia) at the same time – and decided that the drug should be sold under the same name for both categories. So, it’s now officially “Dysport” […]
“Reloxin”, a form of botulinum toxin, and potential competition for Botox, could go on sale in the U.S. soon. The FDA is currently evaluating the product, which has been sold in Europe for approximately 15 years under the name Dysport. It’s a wrinkle-fighter, similar to Botox, and it also has a good track record of […]
